Patents by Inventor Nicholas A. Smith

Nicholas A. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170084052
    Abstract: Apparatus, systems, and methods are disclosed for tracking movement over the ground or other surfaces using two or more spaced apart cameras and an associated processing element to detect ground features in images from the cameras and determine tracking parameters based on the position of the detected ground features in the images.
    Type: Application
    Filed: June 27, 2015
    Publication date: March 23, 2017
    Applicant: SeeScan, Inc.
    Inventors: Mark S. Olsson, Scott A. Powell, Nicholas A. Smith, Garrett A. Newby, Ryan B. Levin, Thomas R. Kok, Michael J. Martin
  • Patent number: 9550458
    Abstract: A retractable step and side bar assembly that can be used for raised vehicles, such as trucks. The retractable step can be configured to provide for significant reach in a deployed position to allow for a user to enter the raised vehicle. Further, in the stowed position the retractable step can be located within the side bar, thereby providing a low profile as well as an enhanced aesthetic appearance.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: January 24, 2017
    Assignee: Lund Motion Products, Inc.
    Inventors: Anthony Nicholas Smith, Eric Charles Bajza, William Franklin Bibb, VI
  • Publication number: 20170014388
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 16, 2016
    Publication date: January 19, 2017
    Applicant: NOVARTIS AG
    Inventors: Kamlesh Jagdis BALA, Andrew BREARLEY, James DALE, Anne-Marie EDWARDS, Mahbub AHMED, David PORTER, Robert Alexander PULZ, Lisa Ann ROONEY, David Andrew SANDHAM, Duncan SHAW, Nichola SMITH, Jessica Louise TAYLOR, Roger John TAYLOR, Thomas Josef Troxler, Joe WRIGGLESWORTH
  • Publication number: 20170000770
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 5, 2017
    Applicant: NOVARTIS AG
    Inventors: Anne-Marie EDWARDS, Mahbub AHMED, Robert Alexander PULZ, Lisa Ann ROONEY, Nichola SMITH, Thomas Josef TROXLER
  • Publication number: 20160373619
    Abstract: Thermal extraction architectures for heat-generating electronic devices such as digital cameras or lights are disclosed.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 22, 2016
    Inventors: Mark S. Olsson, Eric M. Chapman, Nicholas A. Smith
  • Patent number: 9522634
    Abstract: A horizontally moving retractable vehicle step is attachable to a vehicle, such as a low to the ground vehicle like a van. The horizontal vehicle step can provide access to different portions of the vehicle. Further, the horizontal vehicle step can act as a safety mechanism to reduce potential harm to a user in accidentally stepping in gaps between the vehicle and a curb.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: December 20, 2016
    Assignee: Lund Motion Products, Inc.
    Inventor: Anthony Nicholas Smith
  • Patent number: 9522149
    Abstract: Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: December 20, 2016
    Assignee: Novartis AG
    Inventors: Gurdip Bhalay, Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith
  • Publication number: 20160355137
    Abstract: A horizontally moving retractable vehicle step is attachable to a vehicle, such as a low to the ground vehicle like a van. The horizontal vehicle step can provide access to different portions of the vehicle. Further, the horizontal vehicle step can act as a safety mechanism to reduce potential harm to a user in accidentally stepping in gaps between the vehicle and a curb.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 8, 2016
    Inventor: Anthony Nicholas Smith
  • Publication number: 20160355138
    Abstract: A retractable step and side bar assembly that can be used for raised vehicles, such as trucks. The retractable step can be configured to provide for significant reach in a deployed position to allow for a user to enter the raised vehicle. Further, in the stowed position the retractable step can be located within the side bar, thereby providing a low profile as well as an enhanced aesthetic appearance.
    Type: Application
    Filed: September 4, 2015
    Publication date: December 8, 2016
    Inventors: Anthony Nicholas Smith, Eric Charles Bajza, William Franklin Bibb, VI
  • Publication number: 20160261829
    Abstract: Camera head apparatus, systems, and methods for providing wide angle/panoramic images and/or video of the interior of pipes or other cavities using multiple imaging and illumination modules are disclosed.
    Type: Application
    Filed: November 9, 2015
    Publication date: September 8, 2016
    Applicant: SeeScan, Inc.
    Inventors: Mark S. Olsson, Alexander L. Warren, Nicholas A. Smith, Michael J. Martin, Scott A. Powell
  • Patent number: 9403810
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: August 2, 2016
    Assignee: Novartis AG
    Inventors: Kamlesh Jagdis Bala, Andrew Brearley, James Dale, Anne-Marie Edwards, Mahbub Ahmed, David Porter, Robert Alexander Pulz, Lisa Ann Rooney, David Andrew Sandham, Duncan Shaw, Nichola Smith, Jessica Louise Taylor, Roger John Taylor, Thomas Josef Troxler, Joe Wrigglesworth
  • Patent number: 9403833
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: August 2, 2016
    Assignee: Novartis AG
    Inventors: Anne-Marie Edwards, Mahbub Ahmed, Robert Alexander Pulz, Lisa Ann Rooney, Nichola Smith, Thomas Josef Troxler
  • Publication number: 20160068546
    Abstract: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Applicant: Novartis AG
    Inventors: Gurdip BHALAY, Emma BUDD, Graham Charles BLOOMFIELD, Stephen Paul COLLINGWOOD, Andrew DUNSTAN, Lee EDWARDS, Peter GEDECK, Catherine HOWSHAM, Peter HUNT, Thomas Anthony HUNT, Paul OAKLEY, Nichola SMITH
  • Publication number: 20150329549
    Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt or co-crystal thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    Type: Application
    Filed: May 13, 2015
    Publication date: November 19, 2015
    Applicant: NOVARTIS AG
    Inventors: Anne-Marie EDWARDS, Mahbub AHMED, Robert Alexander PULZ, Lisa Ann ROONEY, Nichola SMITH, Thomas Josef TROXLER
  • Publication number: 20150301015
    Abstract: The invention relates to a new method of determining in a sample the presence, absence or concentration of one or more target analytes, such as micro-ribonucleic acids (microRNAs or miRNAs). The invention may therefore relate to a multiplex assay for determining the presence or absence of each target analyte in a group of multiple analytess. The invention uses one or more probes comprising a quadruplex and transmembrane pores.
    Type: Application
    Filed: November 6, 2013
    Publication date: October 22, 2015
    Inventors: Daniel George Fordham, Nicholas Smith, Daniel John Turner
  • Publication number: 20150292286
    Abstract: The present disclosure introduces methods and apparatus for connecting first and second downhole components. A first interface of a first subassembly is coupled to a first component. The first subassembly includes a first connector. A second interface of a second subassembly is coupled to a second component. The second subassembly includes a body and a second connector extendable from the body. The second connector remains communicably connected to the second interface by a conductor extendable from and retractable into the body, including when the second connector is extended away from the body and coupled to the first connector.
    Type: Application
    Filed: April 9, 2014
    Publication date: October 15, 2015
    Applicant: Schlumberger Technology Corporation
    Inventors: Rafael Rodriguez, Nicholas Smith, Mohamed Ali Hussein
  • Patent number: 9139586
    Abstract: A compound of Formula I in free or salt or solvate form, where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 have the meanings as indicated in the specification, is useful for treating diseases which respond to the blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: September 22, 2015
    Assignee: Novartis AG
    Inventors: Gurdip Bhalay, Emma Budd, Graham Charles Bloomfield, Stephen Paul Collingwood, Andrew Dunstan, Lee Edwards, Peter Gedeck, Catherine Howsham, Peter Hunt, Thomas Anthony Hunt, Paul Oakley, Nichola Smith
  • Publication number: 20150224098
    Abstract: Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Application
    Filed: April 20, 2015
    Publication date: August 13, 2015
    Inventors: Gurdip BHALAY, Lee EDWARDS, Catherine HOWSHAM, Peter HUNT, Nichola SMITH
  • Patent number: 9050339
    Abstract: Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: June 9, 2015
    Assignee: Novartis AG
    Inventors: Gurdip Bhalay, Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith
  • Publication number: 20150106741
    Abstract: Technologies are generally described for providing a system to facilitate efficient management and prioritization of conversations, such as emails, in a communication application. Conversations may be prioritized according to user preferences, and an inbox may be rearranged to display important conversations in a user defined order. Conversations may also be associated together so that they may appear together and flow together in the inbox. Additionally, the system may enable a user to delay display of a conversation until a later time based on various criteria such as location, time, and client device. A user may also move important emails to the top of an inbox for prominent display. The system may perform the actions automatically based on observed user behavior. Furthermore, the system may enable touch interactions for interacting with and managing the conversations, and quick controls may be provided for executing commands to perform actions associated with the conversations.
    Type: Application
    Filed: October 15, 2013
    Publication date: April 16, 2015
    Applicant: Microsoft Corporation
    Inventors: Ned Bearer Friend, Matthias Baer, Nicholas Smith, Trevor Neil Lacey, Peter Loren Engrav, Michael Borysenko